(A) Experiment design. BALB/c mice were used to make chimeras with BM mixed from WT, Tcra−/− or Faslpr mice. 3 × 106 AM14.BALB/c B cells were transferred into the mice on day 0, and activated with PL2-3 on days 0, 2 and 4. Spleens were harvested on day 6.
(B, C, & D) ELISpot assays for the number of 4-44+, IgM+, IgG2a+, or IgG2b+ AFCs per spleen.
(E) Number of CD4+, TCRβ+ cells per spleen.
(F) Percent of CD4+, TCRβ+ cells that are activated (CD44hi, CD62Llo).
(G) Number of CD4+, TCRβ+, CD44hi, CD62Llo cells per spleen.
Data were combined from 2 experiments to obtain 6-12 mice per group receiving PL2-3 and 4-8 controls. Bars represent mean and SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 by Mann-Whitney U test.
See also Figure S7.